KVP Capital Advisors, LP
Clone Performance
Feb 2026–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 2 quarters. Past performance does not predict future results.
Portfolio Concentration
32 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $133,897,372 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | +12,700 | 40,200 | $3,909,450 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reducedNew Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| STRO | Sutro Biopharma, Inc. | 226,575 | $5,643,983 | |
| ERAS | Erasca, Inc. | 340,000 | $5,501,200 | |
| TNGX | Tango Therapeutics, Inc. | 230,264 | $4,817,122 | |
| IDYA | IDEAYA Biosciences, Inc. | 79,700 | $2,655,604 | |
| CMPX | Compass Therapeutics, Inc. | 500,000 | $2,645,000 | |
| OCUL | Ocular Therapeutix, Inc | 300,000 | $2,541,000 | |
| VRDN | Viridian Therapeutics, Inc.\DE | 125,000 | $2,445,000 | |
| DRUG | Bright Minds Biosciences Inc. | 31,813 | $2,321,394 | |
| ZURA | Zura Bio Ltd | 373,128 | $2,220,111 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Held | 440,000 | $23,196,800 | 17.32% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 42,900 | $13,821,951 | 10.32% | |
| WHWK |
Whitehawk Therapeutics, Inc.
Healthcare
|
Held | 2,165,997 | $7,472,689 | 5.58% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Held | 36,200 | $6,118,524 | 4.57% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
NEW | 226,575 | $5,643,983 | 4.22% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 53,000 | $5,586,200 | 4.17% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 340,000 | $5,501,200 | 4.11% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Held | 414,000 | $4,939,020 | 3.69% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
NEW | 230,264 | $4,817,122 | 3.60% | |
| INSM |
INSMED Inc
Healthcare
|
Held | 28,497 | $4,659,829 | 3.48% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Held | 133,000 | $4,189,500 | 3.13% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 40,200 | $3,909,450 | 2.92% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Held | 58,250 | $3,724,505 | 2.78% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Held | 121,524 | $3,627,491 | 2.71% | |
| SVRA |
Savara Inc
Healthcare
|
Held | 605,280 | $3,304,828 | 2.47% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Held | 4,750 | $2,816,655 | 2.10% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Held | 91,000 | $2,703,610 | 2.02% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
NEW | 79,700 | $2,655,604 | 1.98% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
NEW | 500,000 | $2,645,000 | 1.98% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
NEW | 300,000 | $2,541,000 | 1.90% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
NEW | 125,000 | $2,445,000 | 1.83% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
NEW | 31,813 | $2,321,394 | 1.73% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
NEW | 373,128 | $2,220,111 | 1.66% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Held | 45,000 | $2,212,200 | 1.65% | |
| IMMX |
Immix Biopharma, Inc.
Healthcare
|
Held | 230,423 | $2,099,153 | 1.57% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Held | 59,700 | $1,998,756 | 1.49% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Held | 26,900 | $1,935,455 | 1.45% | |
| CABA |
Cabaletta Bio, Inc.
Healthcare
|
Held | 505,431 | $1,359,609 | 1.02% | |
| ACHV |
Achieve Life Sciences, Inc.
Healthcare
|
Held | 462,355 | $1,359,323 | 1.02% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Held | 32,700 | $1,315,521 | 0.98% | |
| CELC |
Celcuity Inc.
Healthcare
|
Held | 4,000 | $456,560 | 0.34% | |
| YARW |
Yarrow Bioscience, Inc.
Healthcare
|
Held | 500,551 | $299,329 | 0.22% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.